Extracellular matrix - From basic research to clinical implication: An overview with focus on matrix metalloproteinases;Extrazelluläre matrix - Von der grundlagenforschung zur klinischen bedeutung: Eine übersicht unter besonderer berücksichtigung der matrix metalloproteinasen

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 38, 2004, Pages 1976-1980

  Hamacher, S ^a   Matern, S ^a   Roeb, Elke ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; GELATINASE A; GELATINASE B; HEMOPEXIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEOGLYCAN; SIGNAL PEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1;

CANCER INVASION; CARDIOVASCULAR SYSTEM; EXTRACELLULAR MATRIX; METASTASIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; REVIEW; ANIMAL; CARDIOVASCULAR DISEASE; CLASSIFICATION; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 4644319993     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-831836     Document Type: Review

References (22)

1. Ahonen M, Baker A, Kähäri VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinase-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998: 58: 2310-2315
2. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Science 2002; 115: 3719-3727
3. Bode W. Structural basis of matrix metalloproteinase function. Biochem Soc Symp 2003; 70: 1-14
4. Cha H, Kopetzki E, Huber R, Lanzendorfer M, Brandstetter H. Structural basis of the adaptive molecular recognition by MMP9. J Mol Biol 2002: 320: 1065-1079
5. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002: 295: 2387-2392
6. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Cancer 2002; 2: 161-174
7. Murphy FR, Issa R, Zhou X et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 2002; 277: 11069-11076
8. Nabeshima K, Inoue T, Shimao Y, Sameshima T. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 2002; 524: 255-264
9. Nagase H, Barret A, Jr. Woessner JF. Nomenclature an glossary of the matrix metalloproteinases. Matrix 1992; Suppl 1: 421-424
10. Pei D, Weiss SJ. Furin dependent intracellular activation of the human stromelysin 3 zymogen. Nature 1995; 375: 244-247
11. Ratzinger G, Stoitzner P, Ebner S et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 2002; 168: 4361-4371
12. Roeb E, Behrmann I, Grötzinger J, Breuer B, Matern S. An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist. FASEB J 2000; 14: 1671-1673
13. Roeb E, Dietrich CD, Winograd R, Arndt M, Breuer B, Fass J, Schumpelick V, Matern S. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 2001; 92: 2680-2691
14. Roeb E, Matern S. Matrix metalloproteinasen als Promotoren der Tumorinvasion und Metastasierung. Z Gastroenterol 2001; 39: 807-813
15. Van Wart HE, Birkedal-Hansen H. The cystein switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 1990; 87: 5578-5582
16. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839
17. Vu TH, Shipley JM, Bergers G et al. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998: 93: 411-422
18. Westermarck J, Kähäri VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-792
19. Wilhelm SM, Collier IE, Marmer BL et al. SV40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 17213-17221
20. Woessner JF. The matrix metalloproteinase family. San Diego Academic Press, In Parks WC, Mecham RP (Hrsg). Matrix Metalloproteinases. 1998: 1-14
21. Yu AE, Murphy AN, Stetler-Stevenson WG. Gelatinase A: Structure, Activation, Regulation, and Substrate Specifity. San Diego. Academic Press, In Parks, WC, Mecham RP (eds). Matrix Metalloproteinases. 1998: 85-105
22. Marimastat: BB 2516, TA 2516. Drugs RD 2003; 4: 198-203